Evidence supporting the use of: EGCG
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Epigallocatechin gallate (EGCG) is a polyphenol found predominantly in green tea. Its use in supporting or treating Parkinson’s Disease (PD) is based on preclinical scientific evidence rather than traditional medicine. Several in vitro and animal studies have demonstrated that EGCG exhibits neuroprotective, antioxidant, and anti-inflammatory properties, which may be beneficial in neurodegenerative diseases like PD. EGCG has been shown to reduce oxidative stress, inhibit the aggregation of alpha-synuclein (a protein implicated in PD pathology), and protect dopaminergic neurons in various animal models of PD (PMID: 31467999). Additionally, EGCG may modulate signaling pathways related to cell survival and apoptosis, further contributing to neuroprotection. However, it is important to note that while the preclinical data are promising, there is currently a lack of robust clinical trials in humans to confirm these effects. Most of the supportive evidence comes from laboratory and animal studies, with limited data on safety, optimal dosing, or efficacy in human PD patients. Therefore, EGCG cannot yet be recommended as a validated treatment for PD, but it remains an area of active research. The evidence level is rated as 2, reflecting preclinical promise but insufficient human data.

More about EGCG
More about Parkinson's Disease

Products containing EGCG

We currently have no products on Vitabase that contain this ingredient.